04.24.24
Beiersdorf AG has forged a multi-year partnership with Rubedo Life Sciences to develop innovative skincare products that address the effects of cellular aging.
“For over 140 years, Beiersdorf has been a worldwide leader in skin care with global brands like Nivea, Eucerin, and La Prairie,” said Marco Quarta, CEO, Rubedo Life Sciences. “By combining Rubedo's expertise in cellular senescence with Beiersdorf's complementary expertise in skin care innovation, this partnership may revolutionize the landscape of skin care products, offering consumers new solutions that treat cellular aging for healthy and youthful-looking skin.”
Beiersdorf also joins Rubedo as a strategic investor, having participated in its recent Series A financing round through its Oscar & Paul Corporate Venture Capital Fund.
Officials say the partnership focuses on the exploration of novel compounds derived from Rubedo's extensive research programs, specifically targeting cellular senescence.
Senescent cells accumulate with age and may contribute to age-related skin changes and pathologies. These compounds will be sourced from Rubedo's topical dermatology program, which have senolytic and anti-inflammatory properties.
As part of the partnership, Beiersdorf will conduct in vitro and in silico studies, and will conduct rigorous assessments of the identified compounds from Rubedo. The collaborative effort will culminate in in-vivo human studies, aimed at validating the efficacy of the selected compounds in cosmetic skin care formulations.